C. Hermans
机构：European Organisation for Research and Treatment of Cancer
发表论文 12 篇 · 总被引 2799 次 · h-index 10
代表论文
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial (2014 · The Lancet Oncology · 被引 1193)
- New section of the HITRAN database: Collision-induced absorption (CIA) (2011 · Journal of Quantitative Spectroscopy and Radiative Transfer · 被引 408)
- Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma (2001 · European Journal of Cancer · 被引 393)
- Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group (2000 · Journal of Clinical Oncology · 被引 259)
- Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients (2002 · European Journal of Cancer · 被引 164)
- Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group (2000 · European Journal of Cancer · 被引 153)